| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.825 | 0.004 | 0.825 | Psychostimulant | 0.724 0.004 DBMET02950 | ||
| 0.786 | 0.004 | 0.786 | Spasmolytic | 0.565 0.016 DBMET02950 | ||
| 0.732 | 0.005 | 0.732 | 5 Hydroxytryptamine release stimulant | 0.721 0.006 DBMET02950 | ||
| 0.727 | 0.009 | 0.885 | Antiobesity | 0.885 0.005 DBMET02950 | DBMET02950 | |
| 0.702 | 0.006 | 0.702 | Vasodilator, peripheral | 0.615 0.014 DBMET02950 | ||
| 0.686 | 0.033 | 0.686 | Apoptosis agonist | |||
| 0.613 | 0.005 | 0.613 | Calcium channel L-type activator | 0.592 0.006 DBMET02950 | ||
| 0.599 | 0.01 | 0.599 | Histamine release inhibitor | 0.548 0.017 DBMET02950 | ||
| 0.582 | 0.007 | 0.582 | Vasodilator | 0.397 0.024 DBMET02950 | ||
| 0.574 | 0.004 | 0.574 | Bronchodilator | 0.437 0.005 DBMET02950 | ||
| 0.562 | 0.01 | 0.647 | Cardiotonic | 0.647 0.005 DBMET02950 | DBMET02950 | |
| 0.534 | 0.003 | 0.571 | Peptidyltransferase inhibitor | 0.571 0.003 DBMET02950 | DBMET02950 | |
| 0.524 | 0.013 | 0.524 | Vasodilator, coronary | 0.46 0.022 DBMET02950 | ||
| 0.504 | 0.028 | 0.504 | Antithrombotic | 0.439 0.04 DBMET02950 | ||
| 0.494 | 0.034 | 0.604 | 5 Hydroxytryptamine release inhibitor | 0.604 0.01 DBMET02950 | DBMET02950 | |
| 0.454 | 0.007 | 0.481 | Alpha-N-acetylglucosaminidase inhibitor | 0.481 0.006 DBMET02950 | DBMET02950 | |
| 0.496 | 0.061 | 0.496 | Caspase 9 stimulant | 0.373 0.128 DBMET02950 | ||
| 0.468 | 0.039 | 0.468 | Toll-Like receptor 7 agonist | 0.25 0.148 DBMET02950 | ||
| 0.467 | 0.039 | 0.467 | Toll-Like receptor agonist | 0.259 0.14 DBMET02950 | ||
| 0.464 | 0.038 | 0.565 | Aldehyde oxidase inhibitor | 0.565 0.024 DBMET02950 | DBMET02950 | |
| 0.432 | 0.007 | 0.6 | Antiadrenergic | 0.6 0.005 DBMET02950 | DBMET02950 | |
| 0.428 | 0.007 | 0.597 | Adrenaline antagonist | 0.597 0.005 DBMET02950 | DBMET02950 | |
| 0.406 | 0.006 | 0.406 | Anesthetic local | 0.307 0.012 DBMET02950 | ||
| 0.406 | 0.018 | 0.479 | Interleukin agonist | 0.479 0.01 DBMET02950 | DBMET02950 | |
| 0.395 | 0.015 | 0.536 | 5 Hydroxytryptamine uptake stimulant | 0.536 0.004 DBMET02950 | DBMET02950 | |
| 0.439 | 0.061 | 0.439 | Antibacterial | 0.411 0.072 DBMET02950 | ||
| 0.374 | 0.024 | 0.625 | Peroxidase inhibitor | 0.625 0.004 DBMET02950 | DBMET02950 | |
| 0.347 | 0.003 | 0.347 | Adrenaline agonist | 0.294 0.004 DBMET02950 | ||
| 0.424 | 0.08 | 0.424 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.37 0.129 DBMET02950 | ||
| 0.353 | 0.048 | 0.361 | Calcium channel activator | 0.361 0.043 DBMET02950 | DBMET02950 | |
| 0.309 | 0.005 | 0.309 | Alpha adrenoreceptor agonist | 0.209 0.008 DBMET02950 | ||
| 0.303 | 0.004 | 0.537 | Phenylalanine 4-hydroxylase inhibitor | 0.537 0.002 DBMET02950 | DBMET02950 | |
| 0.367 | 0.072 | 0.367 | Transcription factor NF kappa B inhibitor | 0.367 0.072 DBMET02950 | ||
| 0.289 | 0.004 | 0.289 | Sphingomyelinase inhibitor | 0.218 0.007 DBMET02950 | ||
| 0.344 | 0.067 | 0.39 | Cholesterol antagonist | 0.39 0.051 DBMET02950 | DBMET02950 | |
| 0.379 | 0.103 | 0.415 | Cyclophilin D inhibitor | 0.415 0.083 DBMET02950 | DBMET02950 | |
| 0.285 | 0.017 | 0.285 | Acetylcholine M1 receptor antagonist | 0.237 0.029 DBMET02950 | ||
| 0.299 | 0.034 | 0.414 | Tyrosine 3 hydroxylase inhibitor | 0.414 0.007 DBMET02950 | DBMET02950 | |
| 0.273 | 0.017 | 0.273 | Adenylate cyclase inhibitor | 0.256 0.018 DBMET02950 | ||
| 0.263 | 0.011 | 0.388 | Ferrochelatase inhibitor | 0.388 0.004 DBMET02950 | DBMET02950 | |
| 0.28 | 0.038 | 0.333 | Anesthetic general | 0.333 0.027 DBMET02950 | DBMET02950 | |
| 0.308 | 0.068 | 0.421 | Interleukin 2 agonist | 0.421 0.022 DBMET02950 | DBMET02950 | |
| 0.241 | 0.002 | 0.241 | Baculoviral IAP repeat-containing protein inhibitor | 0.046 0.032 DBMET02950 | ||
| 0.261 | 0.026 | 0.307 | Nitric-oxide synthase stimulant | 0.307 0.01 DBMET02950 | DBMET02950 | |
| 0.308 | 0.076 | 0.4 | Immunostimulant | 0.4 0.049 DBMET02950 | DBMET02950 | |
| 0.296 | 0.068 | 0.338 | Hypoxia-inducible factor 1 alpha inhibitor | 0.338 0.049 DBMET02950 | DBMET02950 | |
| 0.303 | 0.076 | 0.303 | Sodium/bile acid cotransporter inhibitor | 0.266 0.112 DBMET02950 | ||
| 0.242 | 0.018 | 0.248 | Cell wall synthesis inhibitor | 0.248 0.016 DBMET02950 | DBMET02950 | |
| 0.323 | 0.1 | 0.334 | Calpain 2 inhibitor | 0.334 0.095 DBMET02950 | DBMET02950 | |
| 0.301 | 0.078 | 0.301 | Caspase 3 stimulant | |||
| 0.274 | 0.054 | 0.274 | Gastrin inhibitor | 0.254 0.074 DBMET02950 | ||
| 0.224 | 0.004 | 0.224 | NMDA 2A receptor antagonist | 0.154 0.007 DBMET02950 | ||
| 0.223 | 0.006 | 0.237 | Adenylate cyclase stimulant | 0.237 0.005 DBMET02950 | DBMET02950 | |
| 0.215 | 0.004 | 0.215 | Beta adrenoreceptor antagonist | 0.138 0.007 DBMET02950 | ||
| 0.212 | 0.004 | 0.212 | Beta 3 adrenoreceptor antagonist | 0.138 0.007 DBMET02950 | ||
| 0.208 | 0.004 | 0.208 | Alpha 2 adrenoreceptor agonist | 0.163 0.005 DBMET02950 | ||
| 0.222 | 0.035 | 0.222 | 5 Hydroxytryptamine 3E antagonist | 0.208 0.05 DBMET02950 | ||
| 0.214 | 0.028 | 0.214 | Cholinergic antagonist | 0.143 0.057 DBMET02950 | ||
| 0.201 | 0.024 | 0.201 | Acetylcholine muscarinic antagonist | 0.162 0.037 DBMET02950 | ||
| 0.241 | 0.065 | 0.28 | Neuropeptide Y2 antagonist | 0.28 0.031 DBMET02950 | DBMET02950 | |
| 0.205 | 0.029 | 0.205 | Acetylcholine antagonist | 0.138 0.057 DBMET02950 | ||
| 0.259 | 0.088 | 0.303 | Insulysin inhibitor | 0.303 0.057 DBMET02950 | DBMET02950 | |
| 0.223 | 0.053 | 0.264 | Insulin sensitizer | 0.264 0.027 DBMET02950 | DBMET02950 | |
| 0.242 | 0.073 | 0.268 | Calpain inhibitor | 0.268 0.05 DBMET02950 | DBMET02950 | |
| 0.173 | 0.004 | 0.173 | Beta 2 adrenoreceptor antagonist | 0.118 0.006 DBMET02950 | ||
| 0.173 | 0.004 | 0.173 | Beta 1 adrenoreceptor antagonist | 0.121 0.007 DBMET02950 | ||
| 0.176 | 0.012 | 0.176 | NMDA 2 receptor antagonist | 0.167 0.013 DBMET02950 | ||
| 0.238 | 0.076 | 0.308 | DNA synthesis inhibitor | 0.308 0.041 DBMET02950 | DBMET02950 | |
| 0.171 | 0.01 | 0.171 | Toll-Like receptor 3 antagonist | 0.148 0.015 DBMET02950 | ||
| 0.171 | 0.013 | 0.212 | Glutamate dehydrogenase inhibitor | 0.212 0.009 DBMET02950 | DBMET02950 | |
| 0.176 | 0.02 | 0.238 | Mucolytic | 0.238 0.008 DBMET02950 | DBMET02950 | |
| 0.191 | 0.04 | 0.191 | Tubulin antagonist | |||
| 0.236 | 0.085 | 0.264 | Hypoglycemic | 0.264 0.069 DBMET02950 | DBMET02950 | |
| 0.158 | 0.009 | 0.158 | Adrenaline uptake inhibitor | |||
| 0.167 | 0.02 | 0.172 | NMDA receptor antagonist | 0.172 0.019 DBMET02950 | DBMET02950 | |
| 0.164 | 0.023 | 0.26 | Catalase inhibitor | 0.26 0.008 DBMET02950 | DBMET02950 | |
| 0.29 | 0.149 | 0.29 | Analgesic | |||
| 0.169 | 0.028 | 0.244 | Expectorant | 0.244 0.013 DBMET02950 | DBMET02950 | |
| 0.203 | 0.069 | 0.246 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.246 0.044 DBMET02950 | DBMET02950 | |
| 0.27 | 0.137 | 0.303 | GABA C receptor rho-3 antagonist | 0.303 0.114 DBMET02950 | DBMET02950 | |
| 0.141 | 0.011 | 0.141 | Dopamine uptake inhibitor | 0.067 0.032 DBMET02950 | ||
| 0.157 | 0.028 | 0.169 | Ca2+-transporting ATPase inhibitor | 0.169 0.014 DBMET02950 | DBMET02950 | |
| 0.131 | 0.003 | 0.131 | Beta adrenoreceptor agonist | 0.102 0.004 DBMET02950 | ||
| 0.145 | 0.017 | 0.145 | Transcription factor NF kappa B stimulant | 0.087 0.056 DBMET02950 | ||
| 0.16 | 0.033 | 0.16 | Microtubule formation inhibitor | 0.15 0.038 DBMET02950 | ||
| 0.16 | 0.033 | 0.234 | Aminopeptidase B inhibitor | 0.234 0.015 DBMET02950 | DBMET02950 | |
| 0.13 | 0.003 | 0.13 | Beta 2 adrenoreceptor agonist | 0.098 0.004 DBMET02950 | ||
| 0.141 | 0.015 | 0.335 | Glutamate decarboxylase inhibitor | 0.335 0.003 DBMET02950 | DBMET02950 | |
| 0.2 | 0.077 | 0.215 | Neurotrophic factor enhancer | 0.215 0.063 DBMET02950 | DBMET02950 | |
| 0.14 | 0.017 | 0.14 | 5 Hydroxytryptamine uptake inhibitor | |||
| 0.176 | 0.055 | 0.178 | Neurotensin receptor agonist | 0.178 0.052 DBMET02950 | DBMET02950 | |
| 0.177 | 0.056 | 0.177 | Diuretic | 0.164 0.066 DBMET02950 | ||
| 0.167 | 0.046 | 0.167 | Neurotrophic factor | 0.137 0.072 DBMET02950 | ||
| 0.137 | 0.018 | 0.149 | Glutamate (mGluR7) agonist | 0.149 0.012 DBMET02950 | DBMET02950 | |
| 0.2 | 0.081 | 0.309 | Pyruvate kinase inhibitor | 0.309 0.046 DBMET02950 | DBMET02950 | |
| 0.136 | 0.018 | 0.181 | Somatostatin 1 agonist | 0.181 0.008 DBMET02950 | DBMET02950 | |
| 0.131 | 0.013 | 0.166 | Carbonic anhydrase stimulant | 0.166 0.01 DBMET02950 | DBMET02950 | |
| 0.235 | 0.118 | 0.235 | 12-Lipoxygenase inhibitor | |||
| 0.139 | 0.024 | 0.139 | Potassium channel activator | |||
| 0.119 | 0.004 | 0.15 | Diamine oxidase inhibitor | 0.15 0.003 DBMET02950 | DBMET02950 | |
| 0.139 | 0.027 | 0.146 | GABA C receptor rho-1 antagonist | 0.146 0.023 DBMET02950 | DBMET02950 | |
| 0.166 | 0.055 | 0.166 | GABA C receptor rho-2 antagonist | 0.13 0.105 DBMET02950 | ||
| 0.13 | 0.019 | 0.158 | Ornithine decarboxylase inhibitor | 0.158 0.009 DBMET02950 | DBMET02950 | |
| 0.219 | 0.109 | 0.219 | 5 Hydroxytryptamine 1E antagonist | 0.192 0.14 DBMET02950 | ||
| 0.135 | 0.027 | 0.15 | Anabolic | 0.15 0.018 DBMET02950 | DBMET02950 | |
| 0.12 | 0.013 | 0.137 | NMDA receptor agonist | 0.137 0.01 DBMET02950 | DBMET02950 | |
| 0.142 | 0.035 | 0.167 | GABA C receptor antagonist | 0.167 0.022 DBMET02950 | DBMET02950 | |
| 0.124 | 0.02 | 0.131 | Glutamate release inhibitor | 0.131 0.016 DBMET02950 | DBMET02950 | |
| 0.192 | 0.089 | 0.192 | Antimitotic | |||
| 0.134 | 0.032 | 0.288 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.288 0.007 DBMET02950 | DBMET02950 | |
| 0.121 | 0.019 | 0.197 | Aminopeptidase I inhibitor | 0.197 0.007 DBMET02950 | DBMET02950 | |
| 0.116 | 0.015 | 0.116 | Acetylcholine M3 receptor antagonist | 0.079 0.026 DBMET02950 | ||
| 0.135 | 0.033 | 0.247 | Adenylate kinase inhibitor | 0.247 0.01 DBMET02950 | DBMET02950 | |
| 0.133 | 0.032 | 0.133 | Electron transport complex I inhibitor | 0.126 0.04 DBMET02950 | ||
| 0.209 | 0.108 | 0.432 | Superoxide dismutase inhibitor | 0.432 0.021 DBMET02950 | DBMET02950 | |
| 0.105 | 0.016 | 0.105 | Acetylcholine M5 receptor antagonist | 0.078 0.025 DBMET02950 | ||
| 0.125 | 0.037 | 0.193 | Creatine kinase inhibitor | 0.193 0.012 DBMET02950 | DBMET02950 | |
| 0.111 | 0.023 | 0.111 | Nicotinic alpha4beta2 receptor antagonist | 0.086 0.044 DBMET02950 | ||
| 0.169 | 0.082 | 0.226 | Succinate dehydrogenase inhibitor | 0.226 0.032 DBMET02950 | DBMET02950 | |
| 0.123 | 0.036 | 0.133 | Nitric-oxide synthase inhibitor | 0.133 0.031 DBMET02950 | DBMET02950 | |
| 0.242 | 0.155 | 0.306 | Immunosuppressant | 0.306 0.111 DBMET02950 | DBMET02950 | |
| 0.126 | 0.04 | 0.139 | Urease inhibitor | 0.139 0.029 DBMET02950 | DBMET02950 | |
| 0.188 | 0.103 | 0.205 | Cyclic AMP phosphodiesterase inhibitor | 0.205 0.09 DBMET02950 | DBMET02950 | |
| 0.139 | 0.055 | 0.194 | Cathepsin H inhibitor | 0.194 0.024 DBMET02950 | DBMET02950 | |
| 0.14 | 0.057 | 0.188 | Cyclooxygenase 3 inhibitor | 0.188 0.023 DBMET02950 | DBMET02950 | |
| 0.098 | 0.016 | 0.098 | Phospholipase D inhibitor | 0.085 0.028 DBMET02950 | ||
| 0.128 | 0.047 | 0.14 | Transcription factor STAT6 inhibitor | 0.14 0.032 DBMET02950 | DBMET02950 | |
| 0.162 | 0.082 | 0.162 | ATPase inhibitor | 0.144 0.112 DBMET02950 | ||
| 0.125 | 0.046 | 0.265 | GABA C receptor agonist | 0.265 0.012 DBMET02950 | DBMET02950 | |
| 0.113 | 0.037 | 0.184 | Triose-phosphate isomerase inhibitor | 0.184 0.013 DBMET02950 | DBMET02950 | |
| 0.124 | 0.049 | 0.154 | Protein kinase C gamma inhibitor | 0.154 0.029 DBMET02950 | DBMET02950 | |
| 0.109 | 0.035 | 0.156 | NADH dehydrogenase inhibitor | 0.156 0.016 DBMET02950 | DBMET02950 | |
| 0.082 | 0.01 | 0.107 | Alpha-mannosidase inhibitor | 0.107 0.005 DBMET02950 | DBMET02950 | |
| 0.12 | 0.049 | 0.12 | Alpha 2c adrenoreceptor antagonist | 0.109 0.058 DBMET02950 | ||
| 0.111 | 0.041 | 0.135 | Lanosterol 14 alpha demethylase inhibitor | 0.135 0.018 DBMET02950 | DBMET02950 | |
| 0.088 | 0.019 | 0.088 | Caspase 9 inhibitor | |||
| 0.123 | 0.054 | 0.149 | Photosensitizer | 0.149 0.031 DBMET02950 | DBMET02950 | |
| 0.173 | 0.105 | 0.173 | Anticonvulsant | |||
| 0.143 | 0.075 | 0.175 | Thiol protease inhibitor | 0.175 0.051 DBMET02950 | DBMET02950 | |
| 0.12 | 0.052 | 0.18 | Nav1.4 sodium channel blocker | 0.18 0.024 DBMET02950 | DBMET02950 | |
| 0.102 | 0.035 | 0.123 | Inducible nitric-oxide synthase inhibitor | 0.123 0.024 DBMET02950 | DBMET02950 | |
| 0.091 | 0.025 | 0.091 | Vanilloid 4 agonist | 0.079 0.042 DBMET02950 | ||
| 0.149 | 0.083 | 0.203 | Melanin inhibitor | 0.203 0.04 DBMET02950 | DBMET02950 | |
| 0.127 | 0.06 | 0.148 | Proteasome inhibitor | 0.148 0.048 DBMET02950 | DBMET02950 | |
| 0.108 | 0.043 | 0.108 | Calcium antagonist | 0.095 0.051 DBMET02950 | ||
| 0.095 | 0.031 | 0.095 | Estrogen-related receptor beta agonist | 0.086 0.05 DBMET02950 | ||
| 0.113 | 0.049 | 0.144 | UDP-glucose 4-epimerase inhibitor | 0.144 0.031 DBMET02950 | DBMET02950 | |
| 0.139 | 0.076 | 0.141 | Pregnane X receptor agonist | 0.141 0.072 DBMET02950 | DBMET02950 | |
| 0.099 | 0.037 | 0.12 | Granulocyte macrophage colony stimulating factor agonist | 0.12 0.016 DBMET02950 | DBMET02950 | |
| 0.127 | 0.066 | 0.127 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.112 | 0.05 | 0.167 | Carbonic anhydrase III inhibitor | 0.167 0.023 DBMET02950 | DBMET02950 | |
| 0.064 | 0.004 | 0.064 | Ceramide glucosyltransferase inhibitor | 0.059 0.004 DBMET02950 | ||
| 0.071 | 0.011 | 0.105 | Mannosidase inhibitor | 0.105 0.005 DBMET02950 | DBMET02950 | |
| 0.119 | 0.059 | 0.155 | Alpha 2b adrenoreceptor antagonist | 0.155 0.037 DBMET02950 | DBMET02950 | |
| 0.137 | 0.078 | 0.171 | Protein kinase stimulant | 0.171 0.055 DBMET02950 | DBMET02950 | |
| 0.104 | 0.045 | 0.104 | Alpha 2 adrenoreceptor antagonist | 0.095 0.052 DBMET02950 | ||
| 0.06 | 0.002 | 0.06 | Baculoviral IAP repeat-containing protein 3 inhibitor | |||
| 0.069 | 0.012 | 0.069 | Immunoglobulin Fc receptor antagonist | 0.064 0.017 DBMET02950 | ||
| 0.096 | 0.039 | 0.096 | Histamine H2 receptor antagonist | |||
| 0.057 | 0.004 | 0.057 | Beta 1 adrenoreceptor agonist | 0.049 0.004 DBMET02950 | ||
| 0.099 | 0.046 | 0.188 | Aminoacyl-tRNA synthetase inhibitor | 0.188 0.012 DBMET02950 | DBMET02950 | |
| 0.126 | 0.073 | 0.133 | Vanilloid 1 agonist | 0.133 0.061 DBMET02950 | DBMET02950 | |
| 0.079 | 0.026 | 0.21 | Argininosuccinate synthase inhibitor | 0.21 0.007 DBMET02950 | DBMET02950 | |
| 0.126 | 0.073 | 0.134 | Antibacterial (Helicobacter pylori) | 0.134 0.062 DBMET02950 | DBMET02950 | |
| 0.068 | 0.016 | 0.071 | Lysophosphatidic acid 3 receptor antagonist | 0.071 0.014 DBMET02950 | DBMET02950 | |
| 0.12 | 0.068 | 0.142 | Alkylator | 0.142 0.051 DBMET02950 | DBMET02950 | |
| 0.072 | 0.02 | 0.101 | Sphingosine kinase 2 inhibitor | 0.101 0.007 DBMET02950 | DBMET02950 | |
| 0.061 | 0.01 | 0.065 | Membrane dipeptidase inhibitor | 0.065 0.008 DBMET02950 | DBMET02950 | |
| 0.111 | 0.06 | 0.111 | Falcipain 3 inhibitor | 0.104 0.066 DBMET02950 | ||
| 0.091 | 0.041 | 0.091 | Alpha 2a adrenoreceptor antagonist | 0.086 0.044 DBMET02950 | ||
| 0.141 | 0.091 | 0.175 | Interferon gamma antagonist | 0.175 0.054 DBMET02950 | DBMET02950 | |
| 0.077 | 0.028 | 0.148 | Glutamate (mGluR6) antagonist | 0.148 0.004 DBMET02950 | DBMET02950 | |
| 0.067 | 0.019 | 0.067 | Potassium channel (Inward rectifier) blocker | 0.046 0.04 DBMET02950 | ||
| 0.059 | 0.011 | 0.059 | Alpha 1d adrenoreceptor agonist | 0.059 0.011 DBMET02950 | ||
| 0.07 | 0.022 | 0.078 | Glucosylceramidase inhibitor | 0.078 0.017 DBMET02950 | DBMET02950 | |
| 0.063 | 0.016 | 0.085 | NMDA receptor subunit 3A antagonist | 0.085 0.01 DBMET02950 | DBMET02950 | |
| 0.076 | 0.031 | 0.169 | 5 Hydroxytryptamine 2A agonist | 0.169 0.004 DBMET02950 | DBMET02950 | |
| 0.049 | 0.004 | 0.049 | Ileal bile acid transport inhibitor | 0.031 0.005 DBMET02950 | ||
| 0.15 | 0.106 | 0.213 | Phospholipase C inhibitor | 0.213 0.037 DBMET02950 | DBMET02950 | |
| 0.075 | 0.031 | 0.164 | Carbamoyl phosphate synthetase inhibitor | 0.164 0.01 DBMET02950 | DBMET02950 | |
| 0.07 | 0.027 | 0.093 | Acyl-CoA dehydrogenase inhibitor | 0.093 0.018 DBMET02950 | DBMET02950 | |
| 0.069 | 0.026 | 0.088 | Sphingosine kinase inhibitor | 0.088 0.012 DBMET02950 | DBMET02950 | |
| 0.065 | 0.022 | 0.108 | Sphingosine 1-phosphate receptor 1 antagonist | 0.108 0.008 DBMET02950 | DBMET02950 | |
| 0.083 | 0.041 | 0.113 | Sphingosine 1-phosphate receptor antagonist | 0.113 0.015 DBMET02950 | DBMET02950 | |
| 0.118 | 0.076 | 0.118 | Nav1.3 sodium channel blocker | 0.102 0.095 DBMET02950 | ||
| 0.081 | 0.04 | 0.11 | GABA B receptor agonist | 0.11 0.011 DBMET02950 | DBMET02950 | |
| 0.054 | 0.013 | 0.054 | Glucocorticoid antagonist | |||
| 0.044 | 0.004 | 0.044 | Beta 3 adrenoreceptor agonist | 0.015 0.005 DBMET02950 | ||
| 0.071 | 0.032 | 0.135 | NMDA 2C receptor antagonist | 0.135 0.008 DBMET02950 | DBMET02950 | |
| 0.112 | 0.073 | 0.124 | Cholesterol synthesis inhibitor | 0.124 0.061 DBMET02950 | DBMET02950 | |
| 0.041 | 0.002 | 0.041 | Baculoviral IAP repeat-containing protein 2 inhibitor | |||
| 0.086 | 0.049 | 0.086 | Acetylcholine nicotinic antagonist | |||
| 0.062 | 0.025 | 0.112 | 5 Hydroxytryptamine 2 agonist | 0.112 0.008 DBMET02950 | DBMET02950 | |
| 0.096 | 0.059 | 0.126 | Prolactin inhibitor | 0.126 0.034 DBMET02950 | DBMET02950 | |
| 0.138 | 0.102 | 0.158 | Arachidonic acid antagonist | 0.158 0.079 DBMET02950 | DBMET02950 | |
| 0.176 | 0.14 | 0.222 | RNA-directed DNA polymerase inhibitor | 0.222 0.072 DBMET02950 | DBMET02950 | |
| 0.101 | 0.065 | 0.148 | Carbonic anhydrase XV inhibitor | 0.148 0.031 DBMET02950 | DBMET02950 | |
| 0.161 | 0.126 | 0.161 | Hypolipemic | |||
| 0.126 | 0.092 | 0.126 | Aurora-C kinase inhibitor | |||
| 0.063 | 0.029 | 0.145 | Ornithine carbamoyltransferase inhibitor | 0.145 0.01 DBMET02950 | DBMET02950 | |
| 0.038 | 0.004 | 0.038 | Acid ceramidase inhibitor | 0.029 0.01 DBMET02950 | ||
| 0.066 | 0.033 | 0.072 | Cathepsin E inhibitor | 0.072 0.028 DBMET02950 | DBMET02950 | |
| 0.043 | 0.01 | 0.066 | Tryptophan 5 hydroxylase inhibitor | 0.066 0.004 DBMET02950 | DBMET02950 | |
| 0.038 | 0.006 | 0.039 | Lysophosphatidic acid receptor 1 agonist | 0.039 0.006 DBMET02950 | DBMET02950 | |
| 0.059 | 0.027 | 0.103 | Factor IXa inhibitor | 0.103 0.009 DBMET02950 | DBMET02950 | |
| 0.066 | 0.035 | 0.097 | Purinergic P2X1 antagonist | 0.097 0.018 DBMET02950 | DBMET02950 | |
| 0.073 | 0.042 | 0.123 | Sphingosine 1-phosphate receptor 4 agonist | 0.123 0.015 DBMET02950 | DBMET02950 | |
| 0.038 | 0.008 | 0.041 | Purinergic P2Y15 antagonist | 0.041 0.006 DBMET02950 | DBMET02950 | |
| 0.092 | 0.063 | 0.192 | HIV-1 integrase (Overall Integration) inhibitor | 0.192 0.013 DBMET02950 | DBMET02950 | |
| 0.048 | 0.019 | 0.06 | Sphingosine kinase 1 inhibitor | 0.06 0.009 DBMET02950 | DBMET02950 | |
| 0.047 | 0.018 | 0.08 | Kainate receptor agonist | 0.08 0.004 DBMET02950 | DBMET02950 | |
| 0.041 | 0.012 | 0.047 | Lysophosphatidic acid 2 receptor antagonist | 0.047 0.009 DBMET02950 | DBMET02950 | |
| 0.118 | 0.09 | 0.118 | Calcium channel blocker | |||
| 0.075 | 0.048 | 0.135 | Cathepsin G inhibitor | 0.135 0.024 DBMET02950 | DBMET02950 | |
| 0.062 | 0.035 | 0.097 | Alpha 1 adrenoreceptor agonist | 0.097 0.018 DBMET02950 | DBMET02950 | |
| 0.049 | 0.023 | 0.049 | Histamine H2 receptor agonist | 0.044 0.028 DBMET02950 | ||
| 0.104 | 0.078 | 0.104 | Acetylcholine release stimulant | 0.104 0.078 DBMET02950 | ||
| 0.05 | 0.025 | 0.065 | NMDA receptor subunit 3B antagonist | 0.065 0.017 DBMET02950 | DBMET02950 | |
| 0.057 | 0.032 | 0.057 | Neuropeptide Y5 antagonist | |||
| 0.062 | 0.038 | 0.098 | Aminopeptidase microsomal inhibitor | 0.098 0.018 DBMET02950 | DBMET02950 | |
| 0.045 | 0.02 | 0.045 | Oxytocin antagonist | |||
| 0.092 | 0.068 | 0.092 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.057 | 0.033 | 0.059 | Protein 50S ribosomal subunit inhibitor | 0.059 0.032 DBMET02950 | DBMET02950 | |
| 0.078 | 0.055 | 0.1 | Interferon agonist | 0.1 0.029 DBMET02950 | DBMET02950 | |
| 0.056 | 0.032 | 0.056 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.066 | 0.043 | 0.075 | CDC25B inhibitor | 0.075 0.033 DBMET02950 | DBMET02950 | |
| 0.077 | 0.054 | 0.086 | MAP kinase kinase 7 inhibitor | 0.086 0.031 DBMET02950 | DBMET02950 | |
| 0.049 | 0.026 | 0.065 | Neuraminidase (Influenza A) inhibitor | 0.065 0.009 DBMET02950 | DBMET02950 | |
| 0.028 | 0.005 | 0.036 | Neuraminidase (Influenza B) inhibitor | 0.036 0.004 DBMET02950 | DBMET02950 | |
| 0.083 | 0.062 | 0.083 | mTOR complex 2 inhibitor | 0.082 0.063 DBMET02950 | ||
| 0.065 | 0.044 | 0.111 | Neuraminidase (influenza) inhibitor | 0.111 0.014 DBMET02950 | DBMET02950 | |
| 0.032 | 0.012 | 0.032 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.028 0.017 DBMET02950 | ||
| 0.043 | 0.024 | 0.068 | Somatostatin 1 antagonist | 0.068 0.012 DBMET02950 | DBMET02950 | |
| 0.025 | 0.006 | 0.025 | Alpha 2a adrenoreceptor agonist | 0.022 0.008 DBMET02950 | ||
| 0.064 | 0.045 | 0.082 | Interferon inducer | 0.082 0.023 DBMET02950 | DBMET02950 | |
| 0.056 | 0.037 | 0.068 | Protein kinase C eta inhibitor | 0.068 0.029 DBMET02950 | DBMET02950 | |
| 0.031 | 0.013 | 0.035 | 1,3-Beta-glucan synthase inhibitor | 0.035 0.006 DBMET02950 | DBMET02950 | |
| 0.059 | 0.041 | 0.059 | Beta tubulin antagonist | |||
| 0.035 | 0.017 | 0.037 | Endothelial nitric-oxide synthase inhibitor | 0.037 0.015 DBMET02950 | DBMET02950 | |
| 0.1 | 0.084 | 0.1 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.073 | 0.057 | 0.095 | Na+ K+ transporting ATPase inhibitor | 0.095 0.037 DBMET02950 | DBMET02950 | |
| 0.028 | 0.012 | 0.147 | Alpha 1a adrenoreceptor agonist | 0.147 0.003 DBMET02950 | DBMET02950 | |
| 0.118 | 0.102 | 0.154 | Sphingosine 1-phosphate receptor 2 antagonist | 0.154 0.035 DBMET02950 | DBMET02950 | |
| 0.066 | 0.051 | 0.141 | Phosphofructokinase-1 inhibitor | 0.141 0.02 DBMET02950 | DBMET02950 | |
| 0.027 | 0.013 | 0.029 | Vanilloid 2 agonist | 0.029 0.01 DBMET02950 | DBMET02950 | |
| 0.051 | 0.037 | 0.09 | Aconitate hydratase inhibitor | 0.09 0.01 DBMET02950 | DBMET02950 | |
| 0.044 | 0.03 | 0.046 | Histamine H1 receptor agonist | 0.046 0.024 DBMET02950 | DBMET02950 | |
| 0.058 | 0.045 | 0.102 | Neuraminidase inhibitor | 0.102 0.015 DBMET02950 | DBMET02950 | |
| 0.018 | 0.006 | 0.024 | Lysophosphatidic acid receptor 3 agonist | 0.024 0.004 DBMET02950 | DBMET02950 | |
| 0.047 | 0.035 | 0.047 | Dopamine transporter inhibitor | |||
| 0.07 | 0.059 | 0.07 | Adenosine A3 receptor antagonist | |||
| 0.094 | 0.084 | 0.12 | Factor V inhibitor | 0.12 0.038 DBMET02950 | DBMET02950 | |
| 0.014 | 0.005 | 0.014 | Immunosuppressant Cyclosporine-like | |||
| 0.055 | 0.046 | 0.124 | Biliverdin reductase inhibitor | 0.124 0.013 DBMET02950 | DBMET02950 | |
| 0.039 | 0.03 | 0.062 | Toll-Like receptor 2 agonist | 0.062 0.019 DBMET02950 | DBMET02950 | |
| 0.087 | 0.078 | 0.098 | Protease inhibitor | 0.098 0.067 DBMET02950 | DBMET02950 | |
| 0.092 | 0.083 | 0.092 | Folate antagonist | |||
| 0.052 | 0.043 | 0.177 | Alcohol oxidase inhibitor | 0.177 0.008 DBMET02950 | DBMET02950 | |
| 0.02 | 0.012 | 0.023 | Antibiotic Anthracycline-like | 0.023 0.007 DBMET02950 | DBMET02950 | |
| 0.064 | 0.057 | 0.225 | Histidine decarboxylase inhibitor | 0.225 0.011 DBMET02950 | DBMET02950 | |
| 0.028 | 0.02 | 0.028 | Estrogen-related receptor gamma antagonist | |||
| 0.047 | 0.039 | 0.062 | Cytokine production stimulant | 0.062 0.011 DBMET02950 | DBMET02950 | |
| 0.04 | 0.033 | 0.058 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.058 0.008 DBMET02950 | DBMET02950 | |
| 0.021 | 0.014 | 0.021 | Lysophosphatidic acid 1 receptor antagonist | 0.02 0.016 DBMET02950 | ||
| 0.037 | 0.031 | 0.092 | 5 Hydroxytryptamine 2B agonist | 0.092 0.004 DBMET02950 | DBMET02950 | |
| 0.082 | 0.075 | 0.082 | Antihistaminic | |||
| 0.08 | 0.073 | 0.113 | Interleukin 5 antagonist | 0.113 0.029 DBMET02950 | DBMET02950 | |
| 0.031 | 0.025 | 0.042 | Calcitonin receptor agonist | 0.042 0.019 DBMET02950 | DBMET02950 | |
| 0.031 | 0.025 | 0.044 | Glutamate (mGluR3) agonist | 0.044 0.007 DBMET02950 | DBMET02950 | |
| 0.063 | 0.057 | 0.098 | Glutamate (mGluR7) antagonist | 0.098 0.012 DBMET02950 | DBMET02950 | |
| 0.052 | 0.047 | 0.059 | Kallikrein 1 inhibitor | 0.059 0.035 DBMET02950 | DBMET02950 | |
| 0.017 | 0.013 | 0.02 | Aminopeptidase A inhibitor | 0.02 0.011 DBMET02950 | DBMET02950 | |
| 0.025 | 0.02 | 0.025 | CXC chemokine 2 receptor antagonist | |||
| 0.036 | 0.032 | 0.051 | Vascular adhesion protein 1 inhibitor | 0.051 0.015 DBMET02950 | DBMET02950 | |
| 0.086 | 0.084 | 0.086 | Gastric antisecretory | |||
| 0.053 | 0.051 | 0.054 | Androgen agonist | 0.054 0.05 DBMET02950 | DBMET02950 | |
| 0.087 | 0.085 | 0.087 | Nav1.1 sodium channel blocker | |||
| 0.029 | 0.027 | 0.055 | Methionyl aminopeptidase 1 inhibitor | 0.055 0.005 DBMET02950 | DBMET02950 | |
| 0.058 | 0.056 | 0.058 | Neuronal nicotinic receptor antagonist | |||
| 0.073 | 0.071 | 0.073 | Neuropeptide Y antagonist | |||
| 0.039 | 0.038 | 0.046 | Geranyltranstransferase inhibitor | 0.046 0.027 DBMET02950 | DBMET02950 | |
| 0.049 | 0.047 | 0.055 | Leukotriene B4 antagonist | 0.055 0.035 DBMET02950 | DBMET02950 | |
| 0.039 | 0.038 | 0.039 | Phosphorylase inhibitor | |||
| 0.035 | 0.034 | 0.071 | Glutamate (mGluR8) agonist | 0.071 0.005 DBMET02950 | DBMET02950 | |
| 0.045 | 0.044 | 0.061 | Ribonucleoside-diphosphate reductase inhibitor | 0.061 0.034 DBMET02950 | DBMET02950 | |
| 0.018 | 0.017 | 0.018 | Caspase 8 inhibitor | |||
| 0.046 | 0.045 | 0.062 | Ribonucleotide reductase inhibitor | 0.062 0.035 DBMET02950 | DBMET02950 | |
| 0.063 | 0.062 | 0.069 | Protein kinase C beta inhibitor | 0.069 0.05 DBMET02950 | DBMET02950 | |
| 0.058 | 0.057 | 0.07 | Protease 3C (Human rhinovirus) inhibitor | 0.07 0.037 DBMET02950 | DBMET02950 | |
| 0.036 | 0.036 | 0.047 | Oxytocin agonist | 0.047 0.025 DBMET02950 | DBMET02950 | |
| 0.031 | 0.031 | 0.053 | Arginase inhibitor | 0.053 0.013 DBMET02950 | DBMET02950 | |
| 0.067 | 0.067 | 0.091 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.091 0.021 DBMET02950 | DBMET02950 | |
| 0.043 | 0.043 | 0.053 | Glucose-6-phosphate isomerase inhibitor | 0.053 0.025 DBMET02950 | DBMET02950 | |
| 0.036 | 0.037 | 0.05 | Growth hormone release inhibitor | 0.05 0.022 DBMET02950 | DBMET02950 | |
| 0.017 | 0.018 | 0.018 | Alpha 2b adrenoreceptor agonist | 0.018 0.016 DBMET02950 | DBMET02950 | |
| 0.052 | 0.054 | 0.057 | Pregnane X receptor antagonist | 0.057 0.039 DBMET02950 | DBMET02950 | |
| 0.037 | 0.039 | 0.052 | Sphingosine 1-phosphate receptor 1 agonist | 0.052 0.019 DBMET02950 | DBMET02950 | |
| 0.016 | 0.019 | 0.027 | Tryptophan hydroxylase 1 inhibitor | 0.027 0.004 DBMET02950 | DBMET02950 | |
| 0.039 | 0.042 | 0.068 | Aminopeptidase N inhibitor | 0.068 0.021 DBMET02950 | DBMET02950 | |
| 0.062 | 0.067 | 0.091 | Secretase beta inhibitor | 0.091 0.024 DBMET02950 | DBMET02950 | |
| 0.051 | 0.055 | 0.079 | Sphingosine 1-phosphate receptor 3 antagonist | 0.079 0.018 DBMET02950 | DBMET02950 | |
| 0.119 | 0.123 | 0.275 | Growth hormone agonist | 0.275 0.037 DBMET02950 | DBMET02950 | |
| 0.065 | 0.071 | 0.119 | GABA aminotransferase inhibitor | 0.119 0.016 DBMET02950 | DBMET02950 | |
| 0.091 | 0.096 | 0.158 | DOPA decarboxylase inhibitor | 0.158 0.017 DBMET02950 | DBMET02950 | |
| 0.128 | 0.134 | 0.142 | Heat shock protein 70 antagonist | 0.142 0.066 DBMET02950 | DBMET02950 | |
| 0.021 | 0.027 | 0.033 | Glutamate (mGluR1) agonist | 0.033 0.008 DBMET02950 | DBMET02950 | |
| 0.027 | 0.034 | 0.072 | Fumarate hydratase inhibitor | 0.072 0.008 DBMET02950 | DBMET02950 | |
| 0.047 | 0.054 | 0.073 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.073 0.024 DBMET02950 | DBMET02950 | |
| 0.087 | 0.095 | 0.171 | Cystathionine beta-synthase inhibitor | 0.171 0.032 DBMET02950 | DBMET02950 | |
| 0.017 | 0.026 | 0.021 | Toll-Like receptor 8 agonist | 0.021 0.012 DBMET02950 | DBMET02950 | |
| 0.051 | 0.059 | 0.059 | Selectin antagonist | 0.059 0.051 DBMET02950 | DBMET02950 | |
| 0.023 | 0.032 | 0.03 | Thrombin receptor antagonist | 0.03 0.017 DBMET02950 | DBMET02950 | |
| 0.013 | 0.023 | 0.023 | Telomerase stimulant | 0.023 0.005 DBMET02950 | DBMET02950 | |
| 0.093 | 0.103 | 0.22 | Amylase inhibitor | 0.22 0.038 DBMET02950 | DBMET02950 | |
| 0.017 | 0.027 | 0.034 | Aminopeptidase P inhibitor | 0.034 0.007 DBMET02950 | DBMET02950 | |
| 0.023 | 0.034 | 0.032 | Prostaglandin D2 agonist | 0.032 0.02 DBMET02950 | DBMET02950 | |
| 0.017 | 0.028 | 0.027 | Somatostatin 4 antagonist | 0.027 0.013 DBMET02950 | DBMET02950 | |
| 0.018 | 0.031 | 0.027 | Isoleucine-tRNA ligase inhibitor | 0.027 0.008 DBMET02950 | DBMET02950 | |
| 0.026 | 0.04 | 0.04 | Phosphoglycerate kinase inhibitor | 0.04 0.02 DBMET02950 | DBMET02950 | |
| 0.105 | 0.119 | 0.117 | Nav1.6 sodium channel blocker | 0.117 0.101 DBMET02950 | DBMET02950 | |
| 0.092 | 0.106 | 0.102 | Caspase 3 inhibitor | 0.102 0.089 DBMET02950 | DBMET02950 | |
| 0.037 | 0.053 | 0.107 | Neuropeptide agonist | 0.107 0.025 DBMET02950 | DBMET02950 | |
| 0.099 | 0.114 | 0.124 | Nav1.2 sodium channel blocker | 0.124 0.079 DBMET02950 | DBMET02950 | |
| 0.069 | 0.084 | 0.105 | Glutathione S-transferase inhibitor | 0.105 0.033 DBMET02950 | DBMET02950 | |
| 0.026 | 0.044 | 0.034 | Carboxypeptidase B inhibitor | 0.034 0.02 DBMET02950 | DBMET02950 | |
| 0.011 | 0.03 | 0.016 | Nicotinic acid receptor 1 antagonist | 0.016 0.014 DBMET02950 | DBMET02950 | |
| 0.012 | 0.031 | 0.017 | Factor IX inhibitor | 0.017 0.015 DBMET02950 | DBMET02950 | |
| 0.029 | 0.05 | 0.052 | Dopamine D5 agonist | 0.052 0.016 DBMET02950 | DBMET02950 | |
| 0.066 | 0.086 | 0.093 | Histamine N-methyltransferase inhibitor | 0.093 0.053 DBMET02950 | DBMET02950 | |
| 0.123 | 0.145 | 0.223 | Interleukin antagonist | 0.223 0.073 DBMET02950 | DBMET02950 | |
| 0.065 | 0.086 | 0.072 | Glycine receptor antagonist | 0.072 0.071 DBMET02950 | DBMET02950 | |
| 0.038 | 0.059 | 0.044 | Heme oxygenase inhibitor | 0.044 0.027 DBMET02950 | DBMET02950 | |
| 0.078 | 0.103 | 0.095 | Electrolyte absorption antagonist | 0.095 0.065 DBMET02950 | DBMET02950 | |
| 0.029 | 0.054 | 0.057 | Glycine transporter 2 inhibitor | 0.057 0.026 DBMET02950 | DBMET02950 | |
| 0.006 | 0.031 | 0.018 | Glutamate (mGluR6) agonist | 0.018 0.005 DBMET02950 | DBMET02950 | |
| 0.038 | 0.063 | 0.079 | Maillard reaction inhibitor | 0.079 0.025 DBMET02950 | DBMET02950 | |
| 0.045 | 0.07 | 0.063 | Botulinum neurotoxin type A inhibitor | 0.063 0.034 DBMET02950 | DBMET02950 | |
| 0.012 | 0.038 | 0.036 | Somatostatin 2 antagonist | 0.036 0.019 DBMET02950 | DBMET02950 | |
| 0.072 | 0.098 | 0.087 | D-Ala-D-Ala ligase inhibitor | 0.087 0.051 DBMET02950 | DBMET02950 | |
| 0.093 | 0.118 | 0.152 | Toll-Like receptor 2 antagonist | 0.152 0.051 DBMET02950 | DBMET02950 | |
| 0.016 | 0.043 | 0.03 | Lysine carboxypeptidase inhibitor | 0.03 0.016 DBMET02950 | DBMET02950 | |
| 0.097 | 0.124 | 0.131 | Interleukin 4 antagonist | 0.131 0.071 DBMET02950 | DBMET02950 | |
| 0.01 | 0.038 | 0.015 | Purinergic P2Y1 agonist | 0.015 0.012 DBMET02950 | DBMET02950 | |
| 0.029 | 0.057 | 0.053 | Adenosine deaminase inhibitor | 0.053 0.027 DBMET02950 | DBMET02950 | |
| 0.038 | 0.066 | 0.052 | Bombesin 2 receptor antagonist | 0.052 0.031 DBMET02950 | DBMET02950 | |
| 0.077 | 0.107 | 0.095 | Bile acid receptor antagonist | 0.095 0.062 DBMET02950 | DBMET02950 | |
| 0.031 | 0.06 | 0.043 | Sphingosine 1-phosphate receptor agonist | 0.043 0.032 DBMET02950 | DBMET02950 | |
| 0.013 | 0.044 | 0.037 | Glutamate (mGluR1a) agonist | 0.037 0.006 DBMET02950 | DBMET02950 | |
| 0.043 | 0.074 | 0.053 | Bombesin 1 receptor agonist | 0.053 0.05 DBMET02950 | DBMET02950 | |
| 0.099 | 0.132 | 0.111 | DNA repair enzyme inhibitor | 0.111 0.092 DBMET02950 | DBMET02950 | |
| 0.074 | 0.107 | 0.085 | MAP kinase kinase 1 inhibitor | 0.085 0.078 DBMET02950 | DBMET02950 | |
| 0.012 | 0.046 | 0.044 | Somatostatin 5 antagonist | 0.044 0.016 DBMET02950 | DBMET02950 | |
| 0.057 | 0.091 | 0.118 | Glycine receptor agonist | 0.118 0.013 DBMET02950 | DBMET02950 | |
| 0.088 | 0.122 | 0.116 | Aldehyde dehydrogenase inhibitor | 0.116 0.075 DBMET02950 | DBMET02950 | |
| 0.029 | 0.064 | 0.042 | Antimetabolite | 0.042 0.039 DBMET02950 | DBMET02950 | |
| 0.055 | 0.092 | 0.082 | Exportin-1 inhibitor | 0.082 0.022 DBMET02950 | DBMET02950 | |
| 0.02 | 0.057 | 0.049 | Complement C3a chemotactic receptor antagonist | 0.049 0.027 DBMET02950 | DBMET02950 | |
| 0.059 | 0.096 | 0.1 | Keratolytic | 0.1 0.03 DBMET02950 | DBMET02950 | |
| 0.033 | 0.07 | 0.054 | Plasminogen activator inhibitor | 0.054 0.044 DBMET02950 | DBMET02950 | |
| 0.049 | 0.087 | 0.136 | Porphobilinogen synthase inhibitor | 0.136 0.024 DBMET02950 | DBMET02950 | |
| 0.028 | 0.066 | 0.044 | AMPA 4 receptor antagonist | 0.044 0.021 DBMET02950 | DBMET02950 | |
| 0.053 | 0.093 | 0.072 | CYP2A6 inhibitor | 0.072 0.056 DBMET02950 | DBMET02950 | |
| 0.037 | 0.081 | 0.069 | NMDA receptor glycine site agonist | 0.069 0.037 DBMET02950 | DBMET02950 | |
| 0.028 | 0.073 | 0.074 | Glutamate (mGluR group III) agonist | 0.074 0.014 DBMET02950 | DBMET02950 | |
| 0.16 | 0.213 | 0.177 | Transcription factor STAT inhibitor | 0.177 0.173 DBMET02950 | DBMET02950 | |
| 0.031 | 0.086 | 0.069 | Opioid delta receptor antagonist | 0.069 0.041 DBMET02950 | DBMET02950 | |
| 0.038 | 0.093 | 0.051 | Epithelial sodium channel blocker | 0.051 0.045 DBMET02950 | DBMET02950 | |
| 0.021 | 0.081 | 0.059 | Glutamate (mGluR3) antagonist | 0.059 0.009 DBMET02950 | DBMET02950 | |
| 0.056 | 0.117 | 0.083 | Opioid antagonist | 0.083 0.066 DBMET02950 | DBMET02950 | |
| 0.068 | 0.128 | 0.08 | Hematopoietic | 0.08 0.073 DBMET02950 | DBMET02950 | |
| 0.036 | 0.098 | 0.063 | Opioid mu receptor antagonist | 0.063 0.051 DBMET02950 | DBMET02950 | |
| 0.093 | 0.159 | 0.16 | Phospholipase A2 inhibitor | 0.16 0.065 DBMET02950 | DBMET02950 | |
| 0.03 | 0.098 | 0.055 | Glutamate (mGluR group III) antagonist | 0.055 0.016 DBMET02950 | DBMET02950 | |
| 0.042 | 0.111 | 0.073 | Sirtuin 1 inhibitor | 0.073 0.041 DBMET02950 | DBMET02950 | |
| 0.094 | 0.165 | 0.256 | Angiogenesis stimulant | 0.256 0.067 DBMET02950 | DBMET02950 | |
| 0.051 | 0.125 | 0.141 | Monophenol monooxygenase inhibitor | 0.141 0.05 DBMET02950 | DBMET02950 | |
| 0.14 | 0.216 | 0.216 | Lipoxygenase inhibitor | 0.216 0.125 DBMET02950 | DBMET02950 | |
| 0.008 | 0.086 | 0.024 | Methionyl aminopeptidase 2 inhibitor | 0.024 0.019 DBMET02950 | DBMET02950 | |
| 0.03 | 0.109 | 0.066 | Glucagon-like peptide 1 agonist | 0.066 0.044 DBMET02950 | DBMET02950 | |
| 0.018 | 0.099 | 0.038 | Somatostatin 5 agonist | 0.038 0.021 DBMET02950 | DBMET02950 | |
| 0.114 | 0.197 | 0.154 | Platelet antagonist | 0.154 0.14 DBMET02950 | DBMET02950 | |
| 0.027 | 0.116 | 0.048 | Glutamate (mGluR4) antagonist | 0.048 0.023 DBMET02950 | DBMET02950 | |
| 0.027 | 0.124 | 0.055 | Cyclin A1 inhibitor | 0.055 0.049 DBMET02950 | DBMET02950 | |
| 0.098 | 0.197 | 0.14 | Hepatoprotectant | 0.14 0.121 DBMET02950 | DBMET02950 | |
| 0.022 | 0.127 | 0.048 | Glutamate (mGluR8) antagonist | 0.048 0.01 DBMET02950 | DBMET02950 | |
| 0.014 | 0.12 | 0.056 | Urokinase inhibitor | 0.056 0.03 DBMET02950 | DBMET02950 | |
| 0.017 | 0.125 | 0.042 | Opioid mu receptor agonist | 0.042 0.037 DBMET02950 | DBMET02950 | |
| 0.048 | 0.157 | 0.096 | Alcohol dehydrogenase inhibitor | 0.096 0.056 DBMET02950 | DBMET02950 | |
| 0.153 | 0.267 | 0.206 | Apoptosis antagonist | 0.206 0.172 DBMET02950 | DBMET02950 | |
| 0.082 | 0.208 | 0.119 | Mannose-6-phosphate isomerase inhibitor | 0.119 0.103 DBMET02950 | DBMET02950 | |
| 0.076 | 0.216 | 0.124 | Sphingosine 1-phosphate receptor 4 antagonist | 0.124 0.066 DBMET02950 | DBMET02950 | |
| 0.093 | 0.237 | 0.149 | Sphingosine 1-phosphate receptor 5 antagonist | 0.149 0.062 DBMET02950 | DBMET02950 | |
| 0.082 | 0.239 | 0.132 | Hemostatic | 0.132 0.092 DBMET02950 | DBMET02950 | |
| 0.025 | 0.183 | 0.077 | Glutamate receptor agonist | 0.077 0.056 DBMET02950 | DBMET02950 | |
| 0.055 | 0.219 | 0.169 | Thrombolytic | 0.169 0.068 DBMET02950 | DBMET02950 | |
| 0.009 | 0.182 | 0.035 | AMPA receptor agonist | 0.035 0.025 DBMET02950 | DBMET02950 | |
| 0.013 | 0.219 | 0.392 | 5 Hydroxytryptamine agonist | 0.392 0.005 DBMET02950 | DBMET02950 | |
| 0.023 | 0.237 | 0.055 | Protein kinase C iota inhibitor | 0.055 0.046 DBMET02950 | DBMET02950 | |
| 0.007 | 0.222 | 0.114 | 5 Hydroxytryptamine 2C agonist | 0.114 0.006 DBMET02950 | DBMET02950 | |
| 0.137 | 0.394 | 0.185 | MAP kinase kinase 3 inhibitor | 0.185 0.173 DBMET02950 | DBMET02950 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |